LON:CREO

Creo Medical Group (CREO) Share Forecast, Price & News

GBX 24.60

0.00 (0.00%)

(As of 06/1/2023 ET)

Compare

Today's Range: 24.06
▼
24.99
50-Day Range: 24
▼
29
52-Week Range: 19
▼
101.50

Volume: 1.88 million shs
Average Volume: 705,765 shs
Market Capitalization: £86.32 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: GBX 100

Profile Analyst Ratings Chart Competitors Insider Trades Headlines

Creo Medical Group MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 306.5% Upside
GBX 100 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.30
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.87 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Creo Medical Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 100, Creo Medical Group has a forecasted upside of 306.5% from its current price of GBX 24.60.
Amount of Analyst Coverage
Creo Medical Group has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for CREO.

0.0

Dividend Strength

Dividend Yield
Creo Medical Group does not currently pay a dividend.
Dividend Growth
Creo Medical Group does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CREO.

2.4

News and Social Media Coverage

News Sentiment
Creo Medical Group has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Creo Medical Group this week, compared to 0 articles on an average week.
MarketBeat Follows
6 people have added Creo Medical Group to their MarketBeat watchlist in the last 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Creo Medical Group insiders have not sold or bought any company stock.
Percentage Held by Insiders
12.15% of the stock of Creo Medical Group is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 35.00% of the stock of Creo Medical Group is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Creo Medical Group is -175.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Creo Medical Group is -175.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Creo Medical Group has a P/B Ratio of 0.91. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Creo Medical Group (LON:CREO) Stock

Creo Medical Group PLC, through its subsidiaries, engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues; and endotherapy accessories. Creo Medical Group PLC was founded in 2003 and is based in Chepstow, United Kingdom.

Receive CREO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter.

CREO Stock News Headlines

June 1, 2023 | lse.co.uk

UK NICE selects Creo Medical's Speedboat Inject product for assessment

May 31, 2023 | finanznachrichten.de

Creo Medical - Entering phase of accelerating growth inflection

June 1, 2023 | Vantage Point (Ad)

Instantly Find Hidden Trade Opportunities

There’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market.

May 26, 2023 | finance.yahoo.com

Creo Medical Group "really pleased" with first human trial of lung lesion treatment

May 25, 2023 | msn.com

Welsh medtech firm Creo Medical and its groundbreaking lung cancer treating device

May 15, 2023 | finance.yahoo.com

Market Cool On Creo Medical Group PLC's (LON:CREO) Revenues

May 4, 2023 | msn.com

SMALL CAP IDEAS: Creo Medical powers on towards profitability

May 2, 2023 | msn.com

SMALL CAP IDEAS: Creo Medical powers on towards profitability armed with a host of minimally-invasive surgical devices

June 1, 2023 | Vantage Point (Ad)

Instantly Find Hidden Trade Opportunities

April 27, 2023 | proactiveinvestors.com

Creo Medical Group FY22 results and recent funding - Proactive Research Analyst

April 27, 2023 | proactiveinvestors.com

Creo Medical FY22 results and recent funding

April 26, 2023 | msn.com

Creo Medical reports revenue boost following strong orders and growing sales of core technology

April 24, 2023 | finance.yahoo.com

Bullish insiders bet UK£2.1m on Creo Medical Group PLC (LON:CREO)

April 4, 2023 | msn.com

Life sciences firm to create 85 new jobs following Welsh Government funding

March 31, 2023 | msn.com

1 penny stock under 25p that I’d buy today

March 14, 2023 | finance.yahoo.com

While institutions own 41% of Creo Medical Group PLC (LON:CREO), individual investors are its largest shareholders with 55% ownership

March 10, 2023 | msn.com

Creo Medical raises over £33m following final funding round

March 9, 2023 | proactiveinvestors.com

Fundraising lays path to cash flow positivity

February 16, 2023 | marketwatch.com

Creo Medical Stock Offering Raises GBP28.5 Million; Shares Close Lower

February 16, 2023 | lse.co.uk

Creo Medical proposes GBP25.0 million placing and subscription

February 16, 2023 | msn.com

Creo Medical announces major £30m fundraising plans

February 16, 2023 | marketwatch.com

Creo Medical Seeking to Raise GBP30.2 Mln to Maintain Business Momentum

January 25, 2023 | finanznachrichten.de

Creo Medical - Progressing on all fronts

January 23, 2023 | markets.businessinsider.com

Creo Medical (CREO): Progressing on all fronts

January 3, 2023 | msn.com

The Welsh businesses to watch in 2023

November 25, 2022 | uk.finance.yahoo.com

1 penny stock I’d buy for 2023 and hold for a decade

November 4, 2022 | proactiveinvestors.com

Creo Medical under the eye of Proactive research analyst Daniel Appiah

See More Headlines

CREO Price History

30 days | 90 days | 365 days | Advanced Chart

CREO Company Calendar

Last Earnings: 9/23/2020
Today: 6/01/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:CREO
CUSIP: N/A
CIK: N/A
Web: creomedical.com
Phone: +44-1291-606005
Fax: N/A
Employees: 217
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: GBX 100
High Stock Price Forecast: GBX 100
Low Stock Price Forecast: GBX 100
Forecasted Upside/Downside: +306.5%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX (0.14)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-26,940,000.00
Net Margins: -99.14%
Pretax Margin: N/A
Return on Equity: -43.90%
Return on Assets: -21.85%

Debt

Debt-to-Equity Ratio: 23.65
Current Ratio: 1.93
Quick Ratio: 2.19

Sales & Book Value

Annual Sales: £27.17 million
Price / Sales: 3.18
Cash Flow: GBX 10.12 per share
Price / Cash Flow: 2.43
Book Value: GBX 27 per share
Price / Book: 0.91

Miscellaneous

Outstanding Shares: 350,890,000
Free Float: N/A
Market Cap: £86.32 million
Optionable: Not Optionable
Beta: 0.76

Key Executives

Mr. Craig Jonathan Gulliford (Age 51)
CEO & Exec. Director
Comp: $621.72k

Prof. Christopher Paul Hancock (Age 54)
Founder, CTO & Exec. Director
Comp: $474.16k

Mr. Richard John Rees ACA (Age 45)
CFO, Company Sec. & Exec. Director
Comp: $472.35k

Mr. David Gerard Woods (Age 56)
Chief Commercial Officer & Exec. Director
Comp: $555.86k

Mr. Phil Hales
Sales & Marketing Director

Key Competitors

View All Competitors

Insiders

Craig Jonathan Gulliford
Bought 4,478 shares on 1/27/2023
Total: £89,560.00 ($20.00/share)

View All Insider Transactions

CREO Stock - Frequently Asked Questions

Should I buy or sell Creo Medical Group stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Creo Medical Group in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CREO shares.
View CREO analyst ratings or view top-rated stocks.
What is Creo Medical Group's stock price forecast for 2023?: 1 brokers have issued 1-year target prices for Creo Medical Group's shares. Their CREO share price forecasts range from GBX 100 to GBX 100. On average, they anticipate the company's stock price to reach GBX 100 in the next year. This suggests a possible upside of 306.5% from the stock's current price.
View analysts price targets for CREO or view top-rated stocks among Wall Street analysts.
How have CREO shares performed in 2023?: Creo Medical Group's stock was trading at GBX 25.25 on January 1st, 2023. Since then, CREO stock has decreased by 2.6% and is now trading at GBX 24.60.
View the best growth stocks for 2023 here.
How were Creo Medical Group's earnings last quarter?: Creo Medical Group PLC (LON:CREO) announced its earnings results on Wednesday, September, 23rd. The company reported ($6.00) earnings per share (EPS) for the quarter. Creo Medical Group had a negative net margin of 99.14% and a negative trailing twelve-month return on equity of 43.90%.
What other stocks do shareholders of Creo Medical Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Creo Medical Group investors own include MySQUAR (MYSQ) and IQE (IQE).

What is Creo Medical Group's stock symbol?: Creo Medical Group trades on the London Stock Exchange (LON) under the ticker symbol "CREO."
How do I buy shares of Creo Medical Group?: Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Creo Medical Group's stock price today?: One share of CREO stock can currently be purchased for approximately GBX 24.60.
How much money does Creo Medical Group make?: Creo Medical Group (LON:CREO) has a market capitalization of £86.32 million and generates £27.17 million in revenue each year. The company earns £-26,940,000.00 in net income (profit) each year or GBX (0.14) on an earnings per share basis.
How many employees does Creo Medical Group have?: The company employs 217 workers across the globe.
How can I contact Creo Medical Group?: The official website for the company is creomedical.com. The company can be reached via phone at +44-1291-606005.

This page (LON:CREO) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Creo Medical Group (CREO) Share Forecast, Price & News

Creo Medical Group MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Creo Medical Group (LON:CREO) Stock

CREO Stock News Headlines

CREO Price History

CREO Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

CREO Stock - Frequently Asked Questions

Overall MarketRank^™